| Product Code: ETC11477167 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cancer Biological Therapy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cancer Biological Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cancer Biological Therapy Market - Industry Life Cycle |
3.4 Israel Cancer Biological Therapy Market - Porter's Five Forces |
3.5 Israel Cancer Biological Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Israel Cancer Biological Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Cancer Biological Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Cancer Biological Therapy Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
4 Israel Cancer Biological Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing awareness about the benefits of biological therapy in cancer treatment |
4.2.3 Rising investments in research and development for cancer therapies |
4.3 Market Restraints |
4.3.1 High cost associated with biological therapies |
4.3.2 Stringent regulatory approvals for new biological therapies in Israel |
5 Israel Cancer Biological Therapy Market Trends |
6 Israel Cancer Biological Therapy Market, By Types |
6.1 Israel Cancer Biological Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cancer Biological Therapy Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 Israel Cancer Biological Therapy Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 Israel Cancer Biological Therapy Market Revenues & Volume, By Immune Checkpoint Inhibitors, 2021 - 2031F |
6.2 Israel Cancer Biological Therapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Cancer Biological Therapy Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Israel Cancer Biological Therapy Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3 Israel Cancer Biological Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Cancer Biological Therapy Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Cancer Biological Therapy Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Israel Cancer Biological Therapy Market, By Mechanism |
6.4.1 Overview and Analysis |
6.4.2 Israel Cancer Biological Therapy Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.3 Israel Cancer Biological Therapy Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
7 Israel Cancer Biological Therapy Market Import-Export Trade Statistics |
7.1 Israel Cancer Biological Therapy Market Export to Major Countries |
7.2 Israel Cancer Biological Therapy Market Imports from Major Countries |
8 Israel Cancer Biological Therapy Market Key Performance Indicators |
8.1 Patient survival rates post biological therapy treatment |
8.2 Number of clinical trials and research studies conducted in Israel for cancer biological therapies |
8.3 Adoption rate of biological therapies in cancer treatment in Israel |
8.4 Rate of investment in cancer biological therapy research and development in Israel |
9 Israel Cancer Biological Therapy Market - Opportunity Assessment |
9.1 Israel Cancer Biological Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Israel Cancer Biological Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Cancer Biological Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Cancer Biological Therapy Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
10 Israel Cancer Biological Therapy Market - Competitive Landscape |
10.1 Israel Cancer Biological Therapy Market Revenue Share, By Companies, 2024 |
10.2 Israel Cancer Biological Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here